BioCryst Pharmaceuticals Inc (BCRX) stock news · rev $874.8M
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
This BCRX news page leads with what BioCryst Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for BCRX yet. We will not pad this page with generic market recap.
Latest reported BCRX revenue for 2025-12-31 was $874.8M. Net income was $263.9M. Revenue was up 94.1% from 2024-12-31 to 2025-12-31. BCRX currently screens at market cap $1.83B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BCRX stock page; for the tape open the quote page.
BCRX stock news FAQ
What are BCRX's latest revenue and net income?
Latest cached BioCryst Pharmaceuticals Inc (BCRX) revenue for Dec 31, 2025 was $874.8M. Net income was $263.9M. Statements: https://lician.com/financials/bcrx
How did BCRX revenue change from the prior cached period?
Cached BioCryst Pharmaceuticals Inc (BCRX) revenue was up 94.1% from $450.7M (Dec 31, 2024) to $874.8M (Dec 31, 2025). Statements: https://lician.com/financials/bcrx
What is BCRX's market cap?
BioCryst Pharmaceuticals Inc (BCRX) market cap is $1.83B on the latest cached fundamentals snapshot.
What kind of company is BCRX?
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Where is BCRX stock news listed?
Cached stock news for BioCryst Pharmaceuticals Inc (BCRX) is listed at https://lician.com/news/bcrx. Filings: https://lician.com/sec/bcrx
Not investment advice.